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ObituaryNiels Tygstrup (27 May, 1926–20 February, 2009)Dr. Niels Tygstrup (1926–2009)Niels Tygstrup was among the founders of hepatology as a scien-
tiﬁc discipline and a medical profession and throughout his long
career he made important contributions to virtually all aspects of
hepatology. He graduated in medicine 1952 from Copenhagen
University. Decisive for his career were his years as research
assistant at the department of cardiology and in 1965, he became
chief physician at Denmark’s oldest department of medicine at
Rigshospitalet, at only 39 years of age and with neither a doctor-
ate nor authorization as specialist. But his talent and competence
were evident. Four years later, he became professor in internal
medicine, and in 1976 also administrative chief at the Depart-
ment. He held these positions until his retirement in 1996. The
experimental research, however, continued, the last articles being
published after his death.
Niels Tygstrup’s capacity was unusual. Besides the position as
professor and head of a large clinical department, he managed,
through focused research, to establish a new speciality in liver
diseases. The speciality was approved by the Danish Board of
Health and later formally established at several university hospi-
tals. At the same time, he was president of several associations
and councils: The Association for Theoretical and Applied
Therapy (1961–71); the Danish Association for Internal Medicine
(1971–74); the Danish Medical Research Council (1972–79); The
International Association for the Study of the Liver (1966–78);
Liason Ofﬁcer for WHO regarding Liver Diseases (1978–92); foun-
der and, later, president of The European Association for the
Study of the Liver (1976 and 1995). In 1981, he became a member
of the Danish Academy of Science and Letters.
Niels Tygstrup’s research was exceptionally focused, always
driven by curiosity, a commitment to measure everything, and
always bold and original. For his purposes, he made use of all
available methods with unusual skill. He published a large num-
ber of original hepatology papers in international journals, sev-
eral of high impact (Nature, Science, The Lancet, New England
Journal of Medicine, Journal of Clinical Investigation, Hepatology,
and Gastroenterology). Add to this many review articles,
comments, and articles in non-English-language journals (in
Danish, Italian, German, and Dutch languages). Finally, he has
contributed to several textbooks.
In Niels Tygstrup’s research there is a main line and a sideline.
The main line is liver physiology and diseases, elucidated from
multiple angles: liver function in both healthy humans and ani-
mals; epidemiology, pathophysiology, and pathobiochemistry of
liver diseases; the role of the liver in pharmaceutical treatment
of both primary liver diseases and other diseases; treatment of
fulminant acute liver failure; genetic defects in liver diseases.
Overall, Niels Tygstrup’s research presents an almost complete
compendium in hepatology – systematic and beautiful.
Niels Tygstrup established the physiological basis for liver
function and perfusion tests. Together with Kjeld Winkler, he
investigated galactose elimination as well as bromsulfalein clear-Journal of Hepatology 20ance in healthy humans and patients with liver cirrhosis. Their
work is standard liver patophysiology today.
Concurrently with, and after his thesis, Niels Tygstrup
engaged in many other investigations of the healthy and the sick
liver, such as investigation of pressure and ﬂow in the hepatic
vasculature; the role of the liver in hypercholesterolemia; the
effects of ethanol, fructose, and glycerol on liver metabolism;
liver function versus the histologic picture in liver biopsies; the
bilirubin metabolism. Niels Tygstrup also described the occur-
rence of ‘‘Recurrent familial intrahepatic cholestasis’’ on the Faroe
Islands, a disease unknown until then.
Many years later, Tygstrup and coworkers genetically mapped
the enzymatic defect that likely was introduced into the Faroe
population by a proliferative Danish pastor who, in the 1600s,
held an ofﬁce at one of the Islands. Upon its original description,
the disease was named ‘‘Morbus Tygstrup Faroensis’’. Niels
Tygstrup thus achieved what any ambitious physician dreams
about: discovering and giving name to a new disease, and ﬁnally
describing its mechanism.
Niels Tygstrup, in his sixties, when he might have rested
on his well-earned laurels, was captured by the potential of11 vol. 55 j 739–740
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molecular biology to elucidate the biology of liver cells. At the
Mount Sinai Hospital, Albert Einstein College of Medicine in New
York (1990–91), he learned the basic techniques ofmodernmolec-
ular cell biology. Back in Copenhagen, he followed the new lead
with local molecular biologists and published several articles on
clinical molecular biology. Tygstrup, in his liver research, thus
reached all the way from the blackbox physiology of the 1950s
and 1960s, to description of the biology of the individual liver cell.
The sideline of Niels Tygstrup’s research is his contribution in
the 1970s to the systematization and rationalization of patient
treatment. This contribution emanated from Niels Tygstrup’s
Galileic credo to systematize and make measurable the treatment
of not only the individual organ (the liver), but also of the entire
man. Where treatment used to be based on convention and the
individual physician’s experience, Niels Tygstrup became the
trendsetter in a team of Danish physicians and statisticians
who became pioneers in establishing the controlled randomized
trial of treatment effects, which today is the inevitable and
rational basis for the acceptance of new pharmaceutical products
and diagnostic investigations. This was basically unknown to
medical science before 1970.
Niels Tygstrup had many talents. With his systematic
approach to quantiﬁcation of essential liver functions and their
importance in the diseases of the liver, he heralded a new gener-
ation of clinical researchers. His research was furthered, not only
by an astute mind, but also by an unusual knack for experimental
research as, for instance, the trials with the isolated, perfused740 Journal of Hepatology 201porcine liver for treatment of acute liver failure. Moreover, he
was an unusually efﬁcient initiator and organizer. His progress
may also be due to his unobtrusive, frank, and simple relations
to patients, staff and colleagues. Nothing was further from him
than pompous self-promotion or intriguing. He was an upright
and honest man through and through.
Niels Tygstrup was an honorary member of the Swedish as
well as the German Association for Gastroenterology and deliv-
ered named lectures (Barany and Meilahty). He was awarded
the Benzon Prize (1966), the Novo Prize (1976), the Oddi Prize
(1996), and the Hagedorn Prize (1992).Conﬂict of interest
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